Investor Update
Basel, 14 December 2007
Chugai
announces approval of anti-cancer agent Xeloda for new indication of postoperative adjuvant chemotherapy
for colon cancer
Dear Investor,
Please find attached
Chugai’s announcement today regarding the approval of Xeloda in the new indication of postoperative
adjuvant chemotherapy for colon cancer.